Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma

doi:10.3748/wjg.v23.i15.2763

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10478)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

610

WORD

190

HTML

5933

Figures (1-2)

336

Tables (1-6)

248

Sum=7317

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1130

Download

2030

Sum=3160

Apr 21, 2017 (publication date) through Mar 10, 2025

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Apr 21, 2017; 23(15): 2763-2770
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2763

Table 5 Treatment modalities used for patients with hepatocellular carcinoma

Treatment	Hepatitis B (%)	Hepatitis C (%)	Non-viral (%)	P value
TACE	44.5	45.4	39.2	0.099
Ablation	11.1	18.4	10.8	0.011
Resection	24.4	8.8	13.1	< 0.001
Transplant	13.4	21.4	12.3	0.001
Sorafenib	5	4.1	4.1	0.098
Supportive care	21	20	29	< 0.02

HCC: Hepatocellular carcinoma; TACE: Trans arterial chemo embolisation.

Citation: Mohsen W, Rodov M, Prakoso E, Charlton B, Bowen DG, Koorey DJ, Shackel NA, McCaughan GW, Strasser SI. Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma. World J Gastroenterol 2017; 23(15): 2763-2770
URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2763.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2763